Top Markets
Coin of the day
Halberd Corporation Halberd Corporation

Halberd Corporation

HALB
Rank in Stocks #39750
Halberd Corporation is a biotechnology firm dedicated to pioneering therapies... Halberd Corporation is a biotechnology firm dedicated to pioneering therapies for neurodegenerative conditions. The company's therapeutic focus encompasses a broad range of serious illnesses, including post-traumatic stress disorder (PTSD) and chronic traumatic encephalopathy (CTE), Alzheimer's disease, Parkinson's disease, various forms of cancer, and disorders impacting the blood and cerebrospinal fluid. Established in 2009, Halberd Corporation operates from its headquarters in Jackson Center, Pennsylvania.
Share Price
$0.0007
Last synced: 2026-08-13
Market Cap
$361.11K
Change (1 day)
-12.50%
Change (1 year)
-63.16%
Country
US
Trade Halberd Corporation (HALB)

Category

Operating Margin for Halberd Corporation (HALB)
Operating Margin as of 2026 TTM: 0.00%
According to Halberd Corporation latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Halberd Corporation from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.97% -
US
28.81% -
NL
0.00% -
CH
0.00% -
KR
31.23% -
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.